ISHARES IV PLCISHARES IV PLCISHARES IV PLC

ISHARES IV PLC

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪741.25 M‬CHF
Fund flows (1Y)
Dividend yield (indicated)
Discount/Premium to NAV
0.5%
Shares outstanding
‪100.97 M‬
Expense ratio
0.40%

About ISHARES IV PLC


Brand
iShares
Home page
Inception date
Sep 8, 2016
Structure
Irish VCIC
Index tracked
STOXX Global Breakthrough Healthcare (USD)(NR)
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
BlackRock Asset Management Ireland Ltd.
ISIN
IE00BYZK4776
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the STOXX Global Breakthrough Healthcare Index

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
ESG
Geography
Global
Weighting scheme
Equal
Selection criteria
Principles-based

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of May 28, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.79%
Health Technology92.73%
Commercial Services2.74%
Health Services2.28%
Technology Services1.37%
Finance0.47%
Electronic Technology0.21%
Bonds, Cash & Other0.21%
Cash0.18%
Mutual fund0.03%
Stock breakdown by region
1%60%27%10%
North America60.10%
Europe27.36%
Asia10.96%
Oceania1.57%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


2B78 invests in stocks. The fund's major sectors are Health Technology, with 92.73% stocks, and Commercial Services, with 2.74% of the basket. The assets are mostly located in the North America region.
2B78 top holdings are Insulet Corporation and Gilead Sciences, Inc., occupying 2.77% and 2.74% of the portfolio correspondingly.
No, 2B78 doesn't pay dividends to its holders.
2B78 shares are issued by BlackRock, Inc. under the brand iShares. The ETF was launched on Sep 8, 2016, and its management style is Passive.
2B78 expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
2B78 follows the STOXX Global Breakthrough Healthcare (USD)(NR). ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
2B78 invests in stocks.
2B78 price has risen by 0.23% over the last month, and its yearly performance shows a −8.52% decrease. See more dynamics on 2B78 price chart.
NAV returns, another gauge of an ETF dynamics, showed a −12.79% decrease in three-month performance and has decreased by −11.60% in a year.
2B78 trades at a premium (0.52%) meaning the ETF is trading at a higher price than the calculated NAV.